TRBC1-targeting antibody–drug conjugates for the treatment of T cell cancersTushar D. Nichakawade, Suman Paul, Cole Sterling et al.|Nature|2024Cited by 43
NXPE1 alters the sialoglycome by acetylating sialic acids in the human colonBum Seok Lee, Nicolas Wyhs|Nature Communications|2025Cited by 2
TRBC2-targeting antibody–drug conjugates for the treatment of T cell cancersJiaxin Ge, Joshua Urban, Sarah R. DiNapoli et al.|Nature Cancer|2025Cited by 1
A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AMLNour Sabiha Naji, Theodoros Karantanos, Taha Ahmedna et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 1
A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AMLTheodoros Karantanos, Suman Paul, Nour Sabiha Naji et al.|Research Square|2025Cited by 0